made in Belarus
Anti-cancer, hepatitis, multiple sclerosis and COVID‑19
on amino acids that are well assimilated and have no significant side effects. One of them, Inocardil, is as good as the famous “Product” in terms of its anti-ischemic and cardio-tropic effects. Academpharm is developing the production of anti-HIV and hepatitis drugs. While in 2010 domestic drugs accounted for 22 % of the Belarusian market in value terms, since 2015 this figure has exceeded 50 %. The cost of Belarusian analogues is 1.5–2 times lower than that of imported drugs. There are 38 pharmaceutical manufacturers in Belarus. The most important — Belmedpreparaty, Borisov and Nesvizh medical plants, Minskintercaps, Ekzon and Lotios SPC — are united into a pharmaceutical holding. It accounts for about 80 % of production and the same contribution to exports. Belarusian medicines are sold in burowael2011.wixsite.com
T
The Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus is one of the manufacturers of hightech antitumor drugs. It has mastered the production of expensive drugs needed by Belarusian patients in small quantities — up to 120 kg a year. The cost of one bottle of a foreign drug can reach several hundred US dollars. — We are trying to choose expensive drugs for production in order to ensure import substitution and support the budget, — says Svetlana Babitskaya, Director of the Institute of Bioorganic Chemistry. — All these drugs are used in hospitals, and patients receive them free of charge because they are purchased by the state. The production technology of two targeting (molecular targeting, “hitting” specific targets) drugs has been developed, they are used for the treatment of hepatocellular and renal cell carcinoma as well as chronic myeloleukemia. The original product of the manufacturer “Leykovir” is for treatment of patients with multiple sclerosis, it stops the destruction of inflamed areas of the brain. By the way, last year this drug won a gold medal at the St. Petersburg innovation exhibition. The Institute of Physical and Organic Chemistry of the National Academy of Sciences of Belarus produces drugs based
pharmacopoeia.ru
Domestic pharmaceutical companies produce a wide range of drugs, including antitumor drugs, for the treatment of the cardiovascular system and the gastrointestinal tract, as well as for patients with not the most common but very serious diseases, such as multiple sclerosis. At the same time, manufacturers are convinced that Belarusian analogues are no worse than foreign originals, especially since the quality requirements are very stringent.
35 countries worldwide. Their quality is as good as that of their imported analogues. — Our manufacturers buy substances from the same plants in India and China as the world-famous Bayer. 90 % of our factories have been re-equipped and operate making use of modern equipment. When we go to exhibitions in Russia and Ukraine, the first thing that is swept off the shelves is our medicines, — says Vladimir Gapanovich, Director of Lotios SPC. Belarusian scientists are also developing anti-COVID‑19 drugs. — The bioinformatics group has analysed databases and found structures that could become a prototype for a drug that blocks coronavirus proteins. But to start synthesizing it, funding is needed. We therefore anticipate that this work will begin next year. We can expect the production of such a drug in the next few years, — said Svetlana Babitskaya. By Elena Kravets
беларусь. belarus 2020
31
